Better Buy: Eli Lilly vs. Pfizer
Which stock wins in a matchup between these two big drugmakers?
Eli Lilly and Company
LLY
LLY
$118.05
$1.47
1.3%
BATS BZX Real Time Price as of May 22, 2019, 3:38 p.m.
View Interactive LLY Charts
The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.
News & Analysis: Eli Lilly and Company
The Fool has written over 900 articles on Eli Lilly and Company.
All
Market Moves
Podcasts
Earnings
3 Top Diabetes Stocks to Watch in May
These three diabetes stocks should be on your radar right now.
Eli Lilly and Company (LLY) Q1 2019 Earnings Call Transcript
LLY earnings call for the period ending March 31, 2019.
What's Behind Eli Lilly's Mixed Q1 Results
The big drugmaker missed Wall Street revenue expectations in Q1 but narrowly beat earnings estimates. Here's what you need to know.
Better Buy: Eli Lilly vs. GlaxoSmithKline
Eli Lilly and GlaxoSmithKline are both pharma royalty. Which stock is the better buy right now?
Better Buy: AbbVie vs. Eli Lilly
AbbVie and Eli Lilly are two rock-solid dividend plays, but only one is a buy right now.
3 Big Pharmas Trying to Pop the Rebate Bubble
Pharmaceutical companies are suddenly eager to lower drug prices.
Better Buy: GlaxoSmithKline vs. Eli Lilly
Find out which iconic pharmaceutical giant is the better stock pick at the moment.
Better Buy: Eli Lilly vs. Johnson & Johnson
See how the streamlined pharmaceutical company stacks up to the healthcare conglomerate.
Better Buy: Pfizer vs. Eli Lilly
One of these is paying a more generous dividend, but is it right for your portfolio?
